Brain Stimulation Therapy Shows No Benefit for ADHD in New Meta-analysis

 ADHD in the News 2026-07-09


ADHD is a neurodevelopmental condition rooted in delayed or atypical maturation of the prefrontal cortex  (the brain region that governs self-regulation). This maturational lag underlies the hallmark difficulties with attention, hyperactivity, and impulsivity, and also impairs what researchers call executive function: the cognitive toolkit we rely on for working memory, impulse control, mental flexibility, emotional regulation, and the ability to tolerate delays in reward.

View Article: The ADHD Evidence Project, July 2, 2026




Other Articles in this Edition

‎Digital Health Company Sentenced to 72 Months and 24 Months, Respectively, for $90 Million Scheme to Distribute over 37 Million Pills of Adderall 

ADHD medication misuse declines among U.S. adults, study finds

How ADHD affects driving — and what to do about it

Teachers: Here’s How Your Students Say You Can Reach Them (Opinion)

Brain Stimulation Therapy Shows No Benefit for ADHD in New Meta-analysis

I hid my ADHD as a child – the alternative was far worse (Opinion) 

Immune Dysregulation Patterns Differ Between ASD and ADHD

Broad neurodevelopmental spectrum better predicts children’s educational outcomes

Higher Maternal Vitamin D Levels Linked to Lower Risk for ASD and ADHD 

People diagnosed with ADHD and autism more recently show lower genetic risk than earlier cases 

Why have 100,000 people been signed off work with ADHD in the UK?

Is It Time to Move Beyond the DSM? Dispatches From the 2026 APA Annual Meeting — Part 2 (Commentary)